Long term, our vision is to build a company with the following characteristics
* A diversified pipeline of differentiated pharmaceutical products with strong patient benefits.
* A technology focus on genetic chemistry, as the fundamental source of differentiated products.
* An therapeutic area emphasis on cardiovascular/metabolic and infectious diseases.
* An alertness to product and market opportunities in emerging markets in addition to those in the West.
* An international business model with pragmatic, aggressive and cost-effective implementation.
Press Releases:
| Contact Details: |
| Hagmattstrasse 6 |
| Allschwil |
| |
| CH-4123 |
| Switzerland |
| Tel: | 41 61 485 2000 |
| Fax: | 41 61 485 2001 |
| Email: | info@evolva.com |
| WWW: | www.evolva.com/

|
| |
Press Releases on Evolva SA:
|
 |
| Evolva Acquires Pharmaceutical Business of Poalis |
1st September, 2005 |
Evolva |
Evolva Acquires Pharmaceutical Business
of Poalis
2nd
September 2005:
Evolva SA (Allschwil, Switzerland) and Poalis A/S (Copenhagen, Denmark)
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 322 times since April 2007, the link to the organisation's website has been followed 68 times
Search for more companies in Allschwil
Search for more companies in
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Evolva SA